Company
Science
Products & Pipeline
News
Careers
Investors

Locations
Contact

Locations
Contact

Search

Search BioMarin

Back to News Back to Stories

Study of Intraventricular Cerliponase Alfa for CLN2 Disease

May 17, 2018

Related Stories

No related posts.

You’re leaving the BioMarin website.

Links to sites outside of this website are provided as a resource to the viewer. BioMarin accepts no responsibility for the content of linked sites.

Leave this website Close

Contact

Publication Data Request
Report an Adverse Event
Report a Product Complaint
Product Replacement Request
Submit a Medical Information Inquiry

Legal

Supply Chain Statement
Biomarin Data Privacy Center
Terms of Use
Cookie Settings

LinkedIn
X
Instagram
Facebook

© 2024 BioMarin. All rights reserved.